Polymorphs of pridopidine hydrochloride

Crystal Growth and Design

Volumn 12, Issue 6, 2012, Pages 2961-2968

  Zimmermann, Anne ^a   Frøstrup, Brian ^a   Bond, Andrew D ^b  

^a NEUROSEARCH A S   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMBIENT CONDITIONS; DENMARK; HUNTINGTON'S DISEASE; KINETICALLY CONTROLLED; POLYMORPHIC FORMS; SOLID-STATE TRANSITIONS;

DIFFERENTIAL SCANNING CALORIMETRY;

EID: 84861896947     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg300185n     Document Type: Article

References (35)

1. Haleblian, J.; McCrone, W. J. Pharm. Sci. 1969, 58, 911-929
2. Hilfiker, R.; Blatter, F.; von Raumer, M. In Polymorphism: In The Pharmaceutical Industry; Hilfiker, R., Ed.; WILEY-VCH Verlag GmbH & Co.: Weinheim, Germany, 2006; pp 1-20.
3. Changquan, S.; Grant, D. J. W. Pharm. Res. 2001, 18, 274-280
4. Picker-Freyer, K. M.; Liao, X.; Zhang, G.; Wiedmann, T. S. J. Pharm. Sci. 2006, 96, 2111-2124
5. Martino, P. D.; Guyot-Hermann, A.-M.; Conflant, P.; Drache, M.; Guyot, J.-C. Int. J. Pharm. 1996, 128, 1-8
6. Gardner, C. R.; Walsh, C. T.; Almarsson, O. Nat. Rev. Drug. Discovery 2004, 3, 926-934
7. Giron, D.; Mutz, M.; Gamier, S. J. Therm. Anal. Calorim. 2004, 77, 709-747
8. International Conference on Harmonization guidance Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products-chemical substances. U.S. Food and Drug Administration: Rockville, USA, 1999.
9. Guidance for Industry. ANDAs: Pharmaceutical solid polymorphism. Chemistry, manufacturing and controls information. U.S. Food and Drug Administration: Rockville, USA, 2007.
10. Byrn, S.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharm. Res. 1995, 12, 945-954
11. Burger, A.; Ramberger, R. Microchim. Acta. 1979, 72, 259-271
12. Morris, K. R.; Griesser, U. J.; Eckhardt, C. J.; Stowell, J. G. Adv. Drug. Deliv. Rev. 2001, 48, 91-114
13. Guidance for Industry. Q8(R2). Pharmaceutical Development. U.S. Food and Drug Administration: Rockville, USA, 2009.
14. Guidance for Industry. Q9. Quality Risk Management. U.S. Food and Drug Administration: Rockville, USA, 2006.
15. Yu, L. Pharm. Res. 2008, 25, 781-791
16. Mestre, T.; Ferreira, J.; Coelho, M. M.; Rosa, M.; Sampaio, C. Cochrane Database Syst. Rev. 2009, CD006456
17. Mestre, T.; Ferreira, J.; Coelho, M. M.; Rosa, M.; Sampaio, C. Cochrane Database Syst. Rev. 2009, CD006455
18. de Yebenes, J. G.; Landwehrmeyer, B.; Squitieri, F.; Reilmann, R.; Rosser, A.; Barker, R. A.; Saft, C.; Magnet, M. K.; Sword, A.; Rembratt, A. Lancet. Neurol. 2011, 10, 1049-1057
19. Kieburtz, K. Neurotherapeutics 2011, 8, 135
20. Dyhring, T.; Nielsen, E. O.; Sonesson, C.; Pettersson, F.; Karlsson, J.; Svensson, P.; Christophersen, P.; Waters, N. Eur. J. Pharmacol. 2010, 628, 19-26
21. Greenspan, L. J. Res. Natl. Bureau Stand. 1977, 81A, 89-96
22. European Pharmacopoeia, 2.9.34. In European Pharmacopoeia, 7th ed.; Council of Europe: Strasbourg, France, 2010; Vol. 1, pp 305-308.
23. Caira, M. R.; Bourne, S. A.; Oliver, C. L. J. Therm. Anal. Calorim. 2004, 77, 597-605
24. Umeda, T.; Ohnishi, N.; Yokoyama, T.; Kuroda, T.; Kita, Y.; Kuroda, K.; Tatsumi, E.; Matsuda, Y. Chem. Pharm. Bull. 1985, 33, 2073-2078
25. Castro, R. A. E.; Maria, T. M. R.; évora, A. O. L.; Feiteira, J. C.; Silva, M. R.; Beja, A. M.; Canotilho, J.; Eusébio, E. S. Cryst. Growth. Des. 2010, 10, 274-282
26. Yu, L. J. Pharm. Sci. 1995, 84, 966-974
27. Grant, D. J. W.; Mehdizadeh, M.; Chow, A. H.-L.; Fairbrother, J. E. Int. J. Pharm. 1984, 18, 25-38
28. Dunitz, J. D.; Bernstein, J. Acc. Chem. Res. 1995, 28, 193-200
29. Obaidat, R. M.; Alkhamis, K. A.; Salem, M. S. Drug. Dev. Ind. Pharm. 2010, 36, 570-580
30. Otsuka, M.; Kaneniwa, N. J. Pharm. Sci. 1986, 75, 506-511
31. Matsuda, Y.; Tatsumi, E.; Chiba, E.; Miwa, Y. J. Pharm. Sci. 1984, 73, 1453-1460
32. Braun, D. E.; Többens, D. M.; Kahlenberg, V.; Ludescher, J.; Griesser, U. J. Cryst. Growth. Des. 2008, 8, 4109-4119
33. Ostwald, W. Z. Phys. Chem. 1897, 22, 289-330
34. Cardew, P. T.; Davey, R. J. Proc. R. Soc. Lond. A 1985, 398, 415-428
35. Reutzel-Edens, S. M.; Newman, A. W. In Polymorphism: In The Pharmaceutical Industry; Hilfiker, R., Ed.; WILEY-VCH Verlag GmbH & Co.: Weinheim, Germany, 2006; pp 235-258.